2018
DOI: 10.1016/j.bios.2018.03.039
|View full text |Cite
|
Sign up to set email alerts
|

In-vitro model for assessing glucose diffusion through skin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 22 publications
0
18
0
Order By: Relevance
“…This limits the choice of naturally available nutrients to peptides and lipids, restricting access to urea, ammonia, vitamins or sugars (Scharschmidt and Fischbach 2013 ). However, the latter will at least partially be compensated for by diffusion of glucose from the cell culture medium into the dermal and epidermal layers of the model (Khalil et al 2006 ; Ullah et al 2018 ). This provides some selectional advantage for the more invasive P. oleovorans as even a thin stratum corneum layer constitutes a considerable barrier for passive diffusion (Ullah et al 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…This limits the choice of naturally available nutrients to peptides and lipids, restricting access to urea, ammonia, vitamins or sugars (Scharschmidt and Fischbach 2013 ). However, the latter will at least partially be compensated for by diffusion of glucose from the cell culture medium into the dermal and epidermal layers of the model (Khalil et al 2006 ; Ullah et al 2018 ). This provides some selectional advantage for the more invasive P. oleovorans as even a thin stratum corneum layer constitutes a considerable barrier for passive diffusion (Ullah et al 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…All commercial CGM devices are labeled as minimally invasive since they require either a microneedle or a small capsule to be inserted in the subcutis, and they represent an important innovation because they allow reducing the burden of performing multiple daily invasive self-monitoring tests of BG concentrations. Of note, in recent years, there has been a great effort in investigating noninvasive glucose monitoring technologies (see [3][4][5][6] for reviews on the topic). Noninvasive CGM devices represent a further step in reducing the burden related to the daily management of T1D, but unfortunately, they are all still prototypes.…”
Section: Introductionmentioning
confidence: 99%
“…Biocompatibility-related aspects of conducting polymers are very important, because some biosensors and biofuel cells have recently been implanted in the body [151,152] or attached to the skin [153] of the patient. Therefore, the biocompatibility of these devices is a very important issue; otherwise, non-biocompatible structures can cause inflammation and/or other serious disorders [154,155].…”
Section: Biocompatibility-related Aspects Of Some Conducting Polymersmentioning
confidence: 99%